
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
24,400 | 24,800 | 04.04. | |
24,400 | 24,800 | 04.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
25.03. | Scholar Rock stock holds $45 target, buoyed by FDA priority review | ||
25.03. | Scholar Rock gets FDA priority review for its spinal muscular atrophy treatment | ||
25.03. | Scholar Rock Announces FDA Priority Review Designation For Apitegromab | ||
21.03. | Scholar Rock Holding Corp - 8-K, Current Report | ||
17.03. | Scholar Rock releases new phase 3 data on SMA candidate apitegromab |